International study details duodenal adenoma and cancer rates in MAP
An international study of 679 individuals with genetically confirmed MUTYH-associated polyposis (MAP) assessed incidence and progression of duodenal disease. Duodenal adenomas were found in 13.4% at first endoscopy and developed in 22.7% of those initially adenoma-free during follow-up, with duodenal cancer diagnosed in 0.74% of participants; adenoma incidence varied significantly by genotype, and at least four of five cancers were located in the distal duodenum. The authors state that future MAP guidelines should consider genotype-specific surveillance recommendations, assessment of the distal duodenum, and polypectomy of all detectable adenomas.
Most relevant for: Individuals with genetically confirmed MUTYH-associated polyposis undergoing duodenal surveillance endoscopy.
Read the original at The American Journal of GastroenterologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More gastroenterology updates
- New AGA/AASLD Guideline Issues 6 Recommendations on PBC ManagementNov 1, 2026
- Guidance on Selecting Wireless vs Catheter-Based Reflux TestingOct 13, 2026
- Meta-analysis examines relapse risk and treatment in type 1 autoimmune pancreatitisOct 8, 2026
- ACG Issues New Preventive Care Guideline for CirrhosisOct 5, 2026
- US Task Force Issues Consensus Update on Serrated Polyposis SyndromeSep 30, 2026